Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 262 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact262 DOIs

Deposit reference lists for 190 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact190 DOIs

Add abstracts to 97 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact97 DOIs

DOIs for this ISSN

Showing the top 5 of 450 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Systematic Screening for Venous Thromboembolic Events in COV… (10.1055/s-0040-1713167)	Abstract References ORCID	110.78	29
2	The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into… (10.1055/s-0037-1603929)	References ORCID	103.59	117
3	Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identif… (10.1055/s-0040-1705137)	References ORCID	101.47	106
4	Pathological Role of Angiotensin II in Severe COVID-19 (10.1055/s-0040-1713678)	References ORCID	96.98	86
5	Evaluation of the DOAC-Stop® Procedure to Overcome the Effec… (10.1055/s-0038-1657785)	References ORCID	90.31	63
6	Reduced Contraction of Blood Clots in Venous Thromboembolism… (10.1055/s-0038-1635572)	References ORCID	89.62	61
7	The Metabolites of the Dietary Flavonoid Quercetin Possess P… (10.1055/s-0039-1694028)	References ORCID	85.80	51
8	Intermediate-High Risk Pulmonary Embolism (10.1055/s-0039-3401003)	References ORCID	82.17	43
9	Effects of Rivaroxaban on Biomarkers of Coagulation and Infl… (10.1055/s-0040-1701206)	References ORCID	82.17	43
10	Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome… (10.1055/s-0037-1613679)	References ORCID	80.64	40
11	Validation of a Patient-Completed Caprini Risk Score for Ven… (10.1055/s-0037-1607339)	References ORCID	78.99	37
12	BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May E… (10.1055/s-0038-1624566)	References ORCID	76.57	33
13	Bethesda Assay for Detecting Inhibitory Anti-ADAMTS13 Antibo… (10.1055/s-0038-1672187)	References ORCID	76.57	33
14	Cartridge-Based Thromboelastography Can Be Used to Monitor a… (10.1055/s-0039-1696658)	References ORCID	74.57	30
15	Effects of Plasmin on von Willebrand Factor and Platelets: A… (10.1055/s-0038-1660505)	References ORCID	73.86	29
16	Mechanistic Basis for the Differential Effects of Rivaroxaba… (10.1055/s-0038-1649507)	References ORCID	71.57	26
17	Cancer-Associated Thrombosis: Beyond Clinical Practice Guide… (10.1055/s-0038-1675577)	References ORCID	70.75	25
18	Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa… (10.1055/s-0038-1636538)	References ORCID	69.01	23
19	Use of Targeted High-Throughput Sequencing for Genetic Class… (10.1055/s-0038-1676813)	References ORCID	69.01	23
20	Patient Management Strategies and Long-Term Outcomes in Isol… (10.1055/s-0039-1683968)	References ORCID	69.01	23
21	Release of Prometastatic Platelet-Derived Microparticles Ind… (10.1055/s-0037-1613674)	References ORCID	68.09	22
22	Risk of Thrombosis in Patients Presenting with Myocardial In… (10.1055/s-0038-1645875)	References ORCID	68.09	22
23	Patients' Perceptions of Atrial Fibrillation, Stroke Risk, a… (10.1055/s-0038-1666803)	References ORCID	68.09	22
24	Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoa… (10.1055/s-0038-1675578)	References ORCID	68.09	22
25	Sensitivity of a Simple Noninvasive Screening Algorithm for… (10.1055/s-0038-1636537)	References ORCID	67.12	21
26	Visceral Adiposity Is an Independent Determinant of Hypercoa… (10.1055/s-0037-1608942)	References ORCID	66.11	20
27	Reliability and Feasibility of the Self-Administered ISTH-Bl… (10.1055/s-0039-3400483)	References ORCID	66.11	20
28	Subgroup Analysis of Patients with Cancer in XALIA: A Nonint… (10.1055/s-0037-1603924)	References ORCID	65.05	19
29	Direct Oral Anticoagulants or Standard Anticoagulant Therapy… (10.1055/s-0039-1683970)	References ORCID	65.05	19
30	Platelets Protect Cardiomyocytes from Ischemic Damage (10.1055/s-0037-1603928)	References ORCID	63.94	18
31	Sociodemographic, Clinical, and Psychosocial Characteristics… (10.1055/s-0038-1624568)	References ORCID	63.94	18
32	HAEMOcare: The First International Epidemiological Study Mea… (10.1055/s-0039-1688414)	References ORCID	63.94	18
33	Assessment of Thrombotic and Bleeding Tendency in Two Mouse… (10.1055/s-0040-1705138)	References ORCID	63.94	18
34	Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Ri… (10.1055/s-0040-1712143)	References ORCID	63.94	18
35	Idiopathic Renal Infarction and Anticoagulation (10.1055/s-0039-1698757)	Abstract References ORCID	63.38	6
36	ADAMTS13 Deficiency Worsens Colitis and Exogenous ADAMTS13 A… (10.1055/s-0037-1603927)	References ORCID	62.76	17
37	Prothrombin Is Responsible for the Lupus Cofactor Phenomenon… (10.1055/s-0040-1705091)	References ORCID	62.76	17
38	Risk Stratification of Acute Pulmonary Embolism and Determin… (10.1055/s-0040-1708558)	References ORCID	61.52	16
39	Trends in Perioperative Venous Thromboembolism Associated wi… (10.1055/s-0037-1605360)	References ORCID	60.21	15
40	Anti-ADAMTS13 Antibodies and a Novel Heterozygous p.R1177Q M… (10.1055/s-0037-1615252)	References ORCID	60.21	15
41	Inflammatory Bowel Disease and Thrombosis: A National Inpati… (10.1055/s-0040-1710506)	References ORCID	60.21	15
42	Mesenteric Vein Thrombosis Following Platelet Transfusion in… (10.1055/s-0038-1669456)	Abstract References ORCID	58.36	5
43	Impact of Chronic Inflammation, Assessed by hs-CRP, on the A… (10.1055/s-0038-1651523)	References ORCID	57.31	13
44	Complement Component C3 Binds to the A3 Domain of von Willeb… (10.1055/s-0038-1672189)	References ORCID	57.31	13
45	The International Prospective Glanzmann Thrombasthenia Regis… (10.1055/s-0039-1696657)	References ORCID	57.31	13
46	TULA-2 Deficiency Enhances Platelet Functional Responses to… (10.1055/s-0038-1676358)	References ORCID	55.70	12
47	Potential Antimigraine Effects of Warfarin: An Exploration o… (10.1055/s-0039-1692989)	References ORCID	55.70	12
48	Associations between Maternal and Fetal Inherited Thrombophi… (10.1055/s-0037-1603925)	References ORCID	53.96	11
49	Postprandial Increase in Blood Plasma Levels of Tissue Facto… (10.1055/s-0038-1642021)	References ORCID	53.96	11
50	Prediction of Ischemic Events after Percutaneous Coronary In… (10.1055/s-0038-1645876)	References ORCID	53.96	11